Seuraa
Aleksandra Zielińska
Aleksandra Zielińska
Institute of Natural Fibers and Medicinal Plants National Research Institute
Vahvistettu sähköpostiosoite verkkotunnuksessa iwnirz.pl - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology
A Zielińska, F Carreiró, AM Oliveira, A Neves, B Pires, DN Venkatesh, ...
Molecules 25 (16), 3731, 2020
13172020
Nanopesticides in agriculture: Benefits and challenge in agricultural productivity, toxicological risks to human health and environment
M Chaud, EB Souto, A Zielinska, P Severino, F Batain, J Oliveira-Junior, ...
Toxics 9 (6), 131, 2021
2622021
Abundance of active ingredients in sea-buckthorn oil
A Zielińska, I Nowak
Lipids in health and disease 16, 1-11, 2017
2512017
Nanotoxicology and nanosafety: Safety-by-design and testing at a glance
A Zielińska, B Costa, MV Ferreira, D Miguéis, JMS Louros, A Durazzo, ...
International journal of environmental research and public health 17 (13), 4657, 2020
2052020
Microemulsions and nanoemulsions in skin drug delivery
EB Souto, A Cano, C Martins-Gomes, TE Coutinho, A Zielińska, AM Silva
Bioengineering 9 (4), 158, 2022
1832022
Fatty acids in vegetable oils and their importance in cosmetic industry
A Zielińska, I Nowak
Chemik 68 (2), 103-110, 2014
1502014
Anti-inflammatory and anti-cancer activity of citral: Optimization of citral-loaded solid lipid nanoparticles (SLN) using experimental factorial design and LUMiSizer®
A Zielińska, C Martins-Gomes, NR Ferreira, AM Silva, I Nowak, EB Souto
International journal of pharmaceutics 553 (1-2), 428-440, 2018
1242018
Scaffolds for drug delivery and tissue engineering: The role of genetics
A Zielińska, J Karczewski, P Eder, T Kolanowski, M Szalata, K Wielgus, ...
Journal of Controlled Release 359, 207-223, 2023
1002023
Properties, extraction methods, and delivery systems for curcumin as a natural source of beneficial health effects
A Zielińska, H Alves, V Marques, A Durazzo, M Lucarini, TF Alves, ...
Medicina 56 (7), 336, 2020
992020
Nanopharmaceutics: Part I—Clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU
EB Souto, GF Silva, J Dias-Ferreira, A Zielinska, F Ventura, A Durazzo, ...
Pharmaceutics 12 (2), 146, 2020
962020
Loading, release profile and accelerated stability assessment of monoterpenes-loaded solid lipid nanoparticles (SLN)
A Zielińska, NR Ferreira, A Feliczak-Guzik, I Nowak, EB Souto
Pharmaceutical development and technology 25 (7), 832-844, 2020
882020
(+)-Limonene 1, 2-epoxide-loaded slns: Evaluation of drug release, antioxidant activity, and cytotoxicity in an HaCaT cell line
EB Souto, A Zielinska, SB Souto, A Durazzo, M Lucarini, A Santini, ...
International Journal of Molecular Sciences 21 (4), 1449, 2020
882020
Linseed essential oil–source of lipids as active ingredients for pharmaceuticals and nutraceuticals
JR Campos, P Severino, CS Ferreira, A Zielinska, A Santini, SB Souto, ...
Current Medicinal Chemistry 26 (24), 4537-4558, 2019
822019
Elastic and ultradeformable liposomes for transdermal delivery of active pharmaceutical ingredients (APIs)
EB Souto, AS Macedo, J Dias-Ferreira, A Cano, A Zielińska, CM Matos
International Journal of Molecular Sciences 22 (18), 9743, 2021
782021
Uveal melanoma: physiopathology and new in situ-specific therapies
EB Souto, A Zielinska, M Luis, C Carbone, C Martins-Gomes, SB Souto, ...
Cancer Chemotherapy and Pharmacology 84, 15-32, 2019
772019
Development and optimization of alpha-pinene-loaded solid lipid nanoparticles (SLN) using experimental factorial design and dispersion analysis
A Zielińska, NR Ferreira, A Durazzo, M Lucarini, N Cicero, SE Mamouni, ...
Molecules 24 (15), 2683, 2019
732019
Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method
I Pereira, A Zielińska, NR Ferreira, AM Silva, EB Souto
International Journal of Pharmaceutics 549 (1-2), 261-270, 2018
722018
Nanopharmaceutics: Part II—Production scales and clinically compliant production methods
EB Souto, GF Silva, J Dias-Ferreira, A Zielinska, F Ventura, A Durazzo, ...
Nanomaterials 10 (3), 455, 2020
662020
Zielińska, A
EB Souto, R da Ana, SB Souto
probe 337, 275-281, 2007
64*2007
Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis
C Carbone, V Fuochi, A Zielińska, T Musumeci, EB Souto, A Bonaccorso, ...
Colloids and Surfaces B: Biointerfaces 186, 110705, 2020
622020
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20